TAKAYA BROWN: Open Payments
NPI 1285016626 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 12 payments from 8 companies in 2025. Trend: 2023 $680 · 2024 $618 · 2025 $601
Food & beverage: $545Education: $56
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $196 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Corcept Therapeutics | 1 | $56 |
| Lilly USA, LLC | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: COBENFY, Auvelity, Kerendia, Korlym, MOUNJARO, JOURNAVX, Rybelsus, BEVESPI AEROSPHERE.
Industry payments across GA — which companies pay providers there.
